BioNTech vets get $25M seed funding for virtual cancer surveillance startup
BioNTech’s former chief strategy officer Ryan Richardson had a front seat to the creation of a Covid vaccine, and then helped orchestrate BioNTech’s return to its pursuit of new cancer therapies. It was there that ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.